Well, we have done a lot of work to respond to that, Mr. Williams. We've done the warning messages that go to pharmacists if there are duplicate treatments, duplicate drugs. Those have been in place since the 1990s. We do the retrospective analysis now, as I said, case by case to identify where there are patterns of possible abuse.
On June 1st, 2006. See this statement in context.